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INTRODUCTION: Acetylcarnitine is a necessary intermediate in the mitochondrial oxidation of acetate, since it transports the acetyl 
moiety across the mitochondrial membrane [1]. It  has only been observed using hyperpolarized methods [2,3] or with localized 
polarization transfer sequences [5].  Glutamate has been used as an indicator of citric acid cycle (TCA) fluxes following [2-13C]acetate 
infusion [6,7,8], however, the detection of [5-13C]glutamate is hindered by an overlapping [1-13C]acetate resonance in hyperpolarized 
MRS studies and the detection of the glutamate C3 and C4 resonances are challenging due to  large lipid resonances. Here we used 
localized DEPT at high field to monitor 13C enrichment and isotope turnover in glutamate and acetylcarnitine in skeletal muscle in vivo 
following [2-13C]acetate infusion. Two different modeling approaches were evaluated to obtain metabolic fluxes of mitochondrial 
acetate oxidation, either with or without the 13C labeling of acetylcarnitine and the enzymatic fluxes of acetylCoA synthesase (ACS) 
and acetylcarnitine transferase (CAT). 
 
METHODS: Overnight fasted, male Sprague-Dawley rats (n = 5, 200-250g) were anesthetized, a 
catheter placed in the jugular vein for substrate delivery and in the artery for blood sampling.. A 
home built 1H/13C coil was used for localized and unlocalized 1H and 13C NMR data acquisition. 
Animals were infused with 200 umol/kg/min [2-13C]acetate for up to 4 hours. 13C NMR spectra 
were acquired at 14.1T using semi-adiabatic distortionless enhancement by polarization transfer 
(DEPT) combined with a 3D ISIS localization scheme and outer volume suppression [4]. Tissue 
was rapidly excised and frozen in liquid nitrogen for 13C isotopomer analysis of perchloric acid 
extracts and metabolite concentrations. The creatine concentration was measured and cross 
referenced with the 13C creatine signal in vivo to determine 13C concentrations.  Spectra were 
analyzed in LC model and metabolic fluxes were obtained by mathematical modeling in Matlab. 
MODEL: The conventional model (I) is described by a set of isotopic mass balance equations for 
α-ketoglutarate (OG), Glu, oxaloacetate (OAA) and acetylCoA C2 and uses the 13C time courses of 
Glu C2, C3 and C4. The extended model (II) includes the 13C label passage through the 
acetylcarnitine pool and contains additionally equations for cytosolic acetylCoA and 
acetylcarnitine, and uses the 13C labeling time course of acetylcarnitine. Model II also estimates 
total acetylcarnitine. The FE time course of plasma acetate is used in both models as an input 
function. Vdil constitutes the amount of unlabeled precursors entering the acetylCoA pool, VANA the 
loss of 13C label.  
 
RESULTS AND DISCUSSION: Localization with OVS and ISIS suppressed lipid resonances and 
13C labeling of glutamate C2,C3 and C4 and acetylcarnitine C2 were clearly observed in vivo.  The 
13C fractional enrichment of Glu C4, C3, C2 was 0.49 ± 0.04, 0.36 ± 0.04 and 0.44 ± 0.02 
respectively, determined in tissue extracts. Time courses of the 13C tissue concentrations of Glu C4, 
C3, C2 and acetylcarnitine C2 (Fig. 2) were used to obtain metabolic fluxes with two different 
mathematical models. The overall contribution of acetate to TCA cycle oxidation was 80%. The 
estimation of the TCA cycle flux was 20% higher using model II which additionally uses the time 
course of acetylcarnitine labeling. Using this model the acetylcarnitine pool size was determined to be 0.36 ± 0.01 umol/g. Although 
absolute fluxes are different, the relative fluxes compared to VTCA are similar in both models (Table 1 and Fig. 1), with the exception 
of the exchange between glutamate and α-ketoglutarate, VX. 
 
CONCLUSION: The detection of acetylcarnitine and glutamate in vivo using localized DEPT allows a more complete description of 
the mitochondrial oxidation of acetate in skeletal muscle, unhindered by unwanted lipid resonances. A more detailed model was 
constructed to quantify metabolic fluxes and acetylcarnitine concentrations and could lead to an improved understanding of acetate 
oxidation in metabolic disorders.  
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Fig. 1. Two different models were
evaluated. A conventional model (red
italic), and an extended model (green),
which uses the dynamic 13C labeling of
acetylcarnitine. Numbers indicate the
fluxes relative to the TCA cycle flux. 
 
Fig. 2. Time courses of the 13C concentration in Glu C4, Glu C3, Glu C2 and acetylcarnitine C2 following the 
infusion of acetate C2 in skeletal muscle in vivo. Two models were fitted to determine the  metabolic fluxes. 







VTCA 0.14 ± 0.01 0.17 ± 0.03
Vdil 0.03 ± 0.00 0.03 ± 0.01
VX 7.21 ± 6.48 2.62 ± 2.10
VANA 0.02 ± 0.00 0.02 ± 0.01
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